thrombocythemia


Also found in: Dictionary, Thesaurus, Encyclopedia.
Related to thrombocythemia: hydroxyurea, thrombocytosis

thrombocythemia

 [throm″bo-si-the´me-ah]
essential thrombocythemia (hemorrhagic thrombocythemia) a clinical syndrome with repeated spontaneous hemorrhages, either external or into the tissues, and a greatly increased number of circulating platelets, considered one of the myeloproliferative disorders. Called also megakaryocytic leukemia.

throm·bo·cy·to·sis

(throm'bō-sī-tō'sis),
An increase in the number of platelets in the circulating blood.
Synonym(s): thrombocythemia
[thrombocyte + G. -osis, condition]

thrombocythemia

/throm·bo·cy·the·mia/ (throm″bo-si-the´me-ah) thrombocytosis.
essential thrombocythemia , hemorrhagic thrombocythemia a syndrome of repeated spontaneous hemorrhages, either external or into the tissues, and greatly increased number of circulating platelets.

thrombocythaemia, thrombocythemia

throm·bo·cy·to·sis

(throm'bō-sī-tō'sis)
An increase in the number of platelets in the circulating blood.
Synonym(s): thrombocythemia.
[thrombocyte + G. -osis, condition]

throm·bo·cy·to·sis

, thrombocythemia (throm'bō-sī-tō'sis, -sī-thēmē-ă)
An increase in the number of platelets in the circulating blood.
Synonym(s): thrombocythaemia.
[thrombocyte + G. -osis, condition]

thrombocythemia (throm´bōsīthē´mēə),

n an increase in the number of circulating blood platelets.

thrombocythemia

a fixed increase in the number of circulating blood platelets.

essential thrombocythemia, hemorrhagic thrombocythemia
a clinical syndrome with repeated spontaneous hemorrhages, either external or into the tissues, and greatly increased number of circulating platelets.
References in periodicals archive ?
Clinical profile of homozygous JAK2617V4F mutation in patients with polycythemia vera or essential thrombocythemia.
Clinical and laboratory features of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and Treatment.
It was interesting to note that the frequency of JAK2 V617F mutation in essential thrombocythemia was much higher (70%) than that reported in the West, but was comparable in patients with PV and IMF (1,2,5,6).
Platelet hyperaggregability and thrombosis in patients with thrombocythemia.
Essential thrombocythemia (ET) is a blood disorder in which the patient's bone marrow makes an excess of platelets.
The most common BCRJABL1-negative MPNs are polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF).
22 per 100 000 for polycythemia vera and 24 per 100 000 for essential thrombocythemia in the US (13)] than some of the measures estimated here.
essential thrombocythemia (ET), are highly debilitating disorders for which
Treatment indications were essential thrombocythemia (46%), chronic myelogenous leukemia (29%), hepatitis C (11%), hairy cell leukemia (6%), Hodgkin's lymphoma (3%), multiple myeloma (3%), and chronic demyelinating polyneuropathy (3%).